Cargando…
Beneficial Effects of Remote Medical Care for Patients with Hereditary Hemorrhagic Telangiectasia during the COVID-19 Pandemic
Background: Hereditary hemorrhagic telangiectasia (HHT) needs high-quality care and multidisciplinary management. During the COVID-19 pandemic, most non-urgent clinical activities for HHT outpatients were suspended. We conducted an analytical observational cohort study to evaluate whether medical an...
Autores principales: | Gaetani, Eleonora, Agostini, Fabiana, Di Martino, Luigi, Occhipinti, Denis, Passali, Giulio Cesare, Santantonio, Mariaconsiglia, Marano, Giuseppe, Mazza, Marianna, Pola, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199008/ https://www.ncbi.nlm.nih.gov/pubmed/34070664 http://dx.doi.org/10.3390/jcm10112311 |
Ejemplares similares
-
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
por: Gaetani, Eleonora, et al.
Publicado: (2020) -
Hereditary haemorrhagic telangiectasia: A disease not to be forgotten during the COVID‐19 pandemic
por: Gaetani, Eleonora, et al.
Publicado: (2020) -
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group
por: Gaetani, Eleonora, et al.
Publicado: (2019) -
Distribution of Cerebrovascular Phenotypes According to Variants of the ENG and ACVRL1 Genes in Subjects with Hereditary Hemorrhagic Telangiectasia
por: Gaetani, Eleonora, et al.
Publicado: (2022) -
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy
por: Suppressa, Patrizia, et al.
Publicado: (2021)